CRC Pharma
Private Company
Funding information not available
Overview
CRC Pharma is a private, US-based clinical research organization (CRO) established in 2018, providing specialized services in pharmacovigilance, clinical trial management, and CDISC data solutions with a noted focus on oncology. As a service provider, its business model is fee-for-service, positioning it in the competitive but essential CRO sector that supports drug developers. The company appears to be in a revenue-generating stage, leveraging its expertise to serve biotech and pharmaceutical clients, though specific financial details and pipeline ownership are not publicly disclosed. Its leadership is associated with Manoj Jadhav, suggesting a founder-led operational structure.
Technology Platform
Integrated clinical research services platform specializing in clinical trial management, pharmacovigilance, and CDISC data standards implementation for oncology and small molecule programs.
Opportunities
Risk Factors
Competitive Landscape
Competes in the fragmented global CRO market against giants like IQVIA, LabCorp, and PPD, as well as numerous specialized and regional firms. Differentiation is based on focused expertise in oncology and integrated pharmacovigilance/data standards services rather than scale.